AAAAAA

   
Results: 1-3 |
Results: 3
An efficient chiral moderator prepared from inexpensive (+)3-carene: Synthesis of the HIV-1 non-nucleoside reverse transcriptase inhibitor DPC 963
Authors: Kauffman, GS Harris, GD Dorow, RL Stone, BRP Parsons, RL Pesti, JA Magnus, NA Fortunak, JM Confalone, PN Nugent, WA
Citation: Gs. Kauffman et al., An efficient chiral moderator prepared from inexpensive (+)3-carene: Synthesis of the HIV-1 non-nucleoside reverse transcriptase inhibitor DPC 963, ORG LETT, 2(20), 2000, pp. 3119-3121
A new asymmetric 1,4-addition method: application to the synthesis of the HIV non-nucleoside reverse transcriptase inhibitor DPC 961
Authors: Magnus, NA Confalone, PN Storace, L
Citation: Na. Magnus et al., A new asymmetric 1,4-addition method: application to the synthesis of the HIV non-nucleoside reverse transcriptase inhibitor DPC 961, TETRAHEDR L, 41(17), 2000, pp. 3015-3019
Inhibition of clinically relevant mutant variants of HIV-1 by quinazolinone non-nucleoside reverse transcriptase inhibitors
Authors: Corbett, JW Ko, SS Rodgers, JD Gearhart, LA Magnus, NA Bacheler, LT Diamond, S Jeffrey, S Klabe, RM Cordova, BC Garber, S Logue, K Trainor, GL Anderson, PS Erickson-Viitanen, SK
Citation: Jw. Corbett et al., Inhibition of clinically relevant mutant variants of HIV-1 by quinazolinone non-nucleoside reverse transcriptase inhibitors, J MED CHEM, 43(10), 2000, pp. 2019-2030
Risultati: 1-3 |